Amissa Health

Amissa Health is a company dedicated to advancing dementia science through the collection and analysis of real-world health data. They leverage wearable technology, specifically smartwatches, to passively collect vast amounts of health and behavior data from individuals, generating millions of data points per person per year. This approach aims to identify digital biomarkers of early Alzheimer's disease, potentially leading to earlier detection and interventions to slow or prevent the onset of dementia.

Amissa partners with leading research institutions, like Washington University in St. Louis and Wake Forest, to utilize their data platform and accelerate research. Their focus on inclusivity ensures the collection of data from diverse populations, addressing the lack of real-world data in the dementia research community. Amissa's mission is to revolutionize dementia research by providing a rich data source and empowering researchers to develop innovative interventions and ultimately improve the lives of those affected by dementia.

Amissa Health is a company dedicated to advancing dementia science by collecting and analyzing real-world health and behavior data from wearable devices. They believe that by studying large datasets, they can identify digital biomarkers of early Alzheimer's disease and develop interventions to prevent or slow its progression. Their free smartwatch app passively collects millions of data points per person, per year, and they partner with leading researchers to analyze this data and translate it into real-world evidence.

Amissa Health fosters a collaborative and innovative culture focused on advancing dementia science. They value partnerships with leading research institutions and leverage technology to collect real-world data, promoting inclusivity and diversity in research. The company emphasizes a results-oriented approach with a strong commitment to ethical data practices and privacy, reflecting a forward-thinking mindset dedicated to tackling complex healthcare challenges.

Amissa Health recognizes the lack of sufficient real-world data in dementia research, particularly from minority and underrepresented populations, which leads to biased results. They are actively partnering with researchers at Wake Forest and Massachusetts General Hospital to develop a data platform that increases the inclusion of diverse study participants and makes the data accessible to other researchers. This commitment to diversity and inclusion aims to ensure that dementia research is representative and beneficial to a wider range of individuals.